Microbial Pathogenesis: Mechanisms of Infection, Virulence, and Host Defense

Microbial Pathogenesis: Mechanisms of Infection, Virulence, and Host Defense

Microbial Adherence

Adherence is the initial and essential step in the establishment of microbial infection. It involves the attachment of microorganisms to host tissues, which is necessary for colonization and subsequent disease development.

• Infection vs. Disease: Infection refers to the growth of microorganisms on or in the host, while disease is the result of tissue damage or injury that impairs host function.

• Adherence Molecules: Pathogens adhere to epithelial cells via specific interactions between molecules on the pathogen (adhesins) and host tissue receptors. These interactions are often highly specific and critical for infection.

• Portals of Entry: Pathogens enter the host through mucous membranes, skin, or breaches in these barriers (e.g., wounds, insect bites). The portal of entry is often crucial for infection; for example, Streptococcus pneumoniae causes disease if it reaches the respiratory tract but is destroyed in the stomach.

• Adhesins and Receptors: Adhesins are glycoproteins or lipoproteins on the pathogen surface that bind to complementary host molecules (e.g., glycoproteins, gangliosides, globosides).

• Adherence Structures: Capsules, fimbriae, pili, and flagella facilitate adherence. Capsules are sticky and contain specific receptors; fimbriae and pili are protein structures that bind host cell glycoproteins. Flagella may also assist in adherence but are less important than fimbriae and pili.

• Examples: Neisseria gonorrhoeae uses Opa protein and pili to adhere to mucosal epithelial cells; influenza virus uses hemagglutinin to bind respiratory tract cells.

Colonization and Invasion

After adherence, pathogens must colonize and multiply at the infection site. Colonization is the growth of microorganisms after gaining access to host tissues, often beginning at mucous membranes.

• Tissue Specificity: Pathogens often show rigid tissue specificity, which aids in diagnosis.

• Mucous Membranes: Composed of epithelial cells that secrete mucus, these membranes inhibit microbial attachment, but some microbes can adhere and colonize.

• Biofilms: Pathogens may form biofilms, complex communities of microorganisms attached to surfaces, which enhance colonization and resistance to host defenses.

• Example – Dental Caries: Oral streptococci (S. sobrinus, S. mutans) colonize teeth by producing capsules and exopolysaccharides (dextran), forming dental plaque. These bacteria ferment sugars to lactic acid, leading to tooth decay.

• Invasion: The ability of a pathogen to enter host cells or tissues, spread, and cause disease. Localized infections may remain at the entry site, while systemic infections involve spread via the bloodstream (bacteremia, septicemia, viremia).

Pathogenicity, Virulence, and Virulence Attenuation

Pathogenicity is the ability of a microorganism to cause disease, while virulence is a quantitative measure of pathogenicity.

• Virulence Factors: Molecules produced by pathogens that enhance their ability to cause disease (e.g., toxins, enzymes).

• Measuring Virulence: The LD50 (lethal dose 50) is the number of cells or virions required to kill 50% of a host population. Highly virulent pathogens have low LD50 values.

• Example: Encapsulated S. pneumoniae is highly virulent (low LD50), while Salmonella enterica requires a much higher dose to cause disease.

• Attenuation: The decrease or loss of virulence, often occurring during laboratory culture. Attenuated strains are used in vaccine development (e.g., measles, mumps, rubella vaccines).

Genetics of Virulence and the Compromised Host

Virulence is determined by genetic and physiological features of both the pathogen and the host.

• Genetic Basis: Virulence genes may be located on chromosomes, plasmids, or mobile genetic elements (e.g., pathogenicity islands, R plasmids).

• Pathogenicity Islands: Clusters of virulence genes in the chromosome (e.g., SPI1 and SPI2 in Salmonella), often encoding secretion systems and toxins.

• Horizontal Gene Transfer: Virulence factors can be transferred between species via plasmids, transposons, or bacteriophages.

• Compromised Hosts: Individuals with weakened immune systems (due to age, disease, medical procedures, or lifestyle) are more susceptible to infection, especially by opportunistic pathogens.

Enzymes as Virulence Factors

Many pathogens produce enzymes that facilitate invasion and tissue destruction.

• Tissue-Destroying Enzymes:

  • Hyaluronidase: Breaks down hyaluronic acid in connective tissue, promoting spread (e.g., Streptococcus, Staphylococcus).

  • Collagenase: Destroys collagen, allowing deeper tissue invasion (e.g., Clostridium in gas gangrene).

  • Proteases, Nucleases, Lipases: Degrade host proteins, nucleic acids, and lipids.

  • Streptokinase: Dissolves fibrin clots, aiding spread (used medically to dissolve blood clots).

  • Coagulase: Promotes fibrin clot formation, protecting bacteria from immune attack (e.g., Staphylococcus aureus).

• Enzyme Activities at Mucosal Surfaces:

  • Lysozyme Resistance: Some bacteria modify their peptidoglycan to resist lysozyme.

  • IgA Proteases: Cleave secretory IgA antibodies, countering mucosal immunity (e.g., Neisseria species).

AB-Type Exotoxins

Exotoxins are secreted proteins that cause damage at sites distant from infection. AB toxins consist of two subunits: A (active) and B (binding).

• Mechanism: The B subunit binds to host cell receptors, facilitating entry of the A subunit, which disrupts cellular processes.

• Examples:

  • Diphtheria Toxin: Inhibits protein synthesis by ADP-ribosylating elongation factor 2 (EF-2). Encoded by a lysogenic phage gene.

  • Botulinum Toxin: Blocks acetylcholine release at neuromuscular junctions, causing flaccid paralysis (botulism).

  • Tetanus Toxin: Blocks inhibitory neurotransmitter release, causing spastic paralysis (tetanus).

  • Cholera Toxin: Activates adenylate cyclase in intestinal cells, increasing cAMP and causing massive fluid loss (diarrhea).

  • Shiga and Shiga-like Toxins: Inhibit protein synthesis in intestinal cells, causing cell death and bloody diarrhea.

Cytolytic and Superantigen Exotoxins

Cytolytic toxins destroy host cells by disrupting membranes, while superantigen toxins trigger excessive immune responses.

• Cytolytic Exotoxins (Cytotoxins):

  • Hemolysins: Lyse red blood cells (e.g., streptolysin O, staphylococcal α-toxin).

  • Lecithinases/Phospholipases: Destroy membrane phospholipids (e.g., Clostridium perfringens α-toxin).

  • Leukocidins: Lyse white blood cells, reducing immune response.

• Superantigen Exotoxins:

  • Produced by Staphylococcus aureus and Streptococcus pyogenes.

  • Cause massive, non-specific activation of T lymphocytes, leading to cytokine storm, systemic inflammation, hypotension, organ failure, and shock (e.g., toxic shock syndrome).

Endotoxins

Endotoxins are toxic lipopolysaccharides (LPS) found in the outer membrane of gram-negative bacteria. They are released upon cell lysis and are less potent than exotoxins.

• Structure: LPS consists of O-specific polysaccharide, core polysaccharide, and lipid A (toxic component).

• Effects: Induce fever (via cytokine release), diarrhea, tachycardia, inflammation, complement activation, and blood coagulation. Large doses can cause hemorrhagic shock and kidney failure.

• Toxicity: Endotoxins are generally less toxic than exotoxins (e.g., LD50 for endotoxin is much higher than for botulinum toxin).

• Detection: The Limulus amoebocyte lysate (LAL) assay uses horseshoe crab blood extracts to detect endotoxin contamination in pharmaceuticals and clinical samples.

Feature	Exotoxins	Endotoxins
Chemical Nature	Proteins (often with enzymatic activity)	Lipopolysaccharide (LPS)
Source	Gram-positive and Gram-negative bacteria	Gram-negative bacteria only
Secretion	Actively secreted	Released upon cell lysis
Toxicity	Highly toxic (low LD50)	Less toxic (high LD50)
Immunogenicity	Highly immunogenic (can be used as vaccines)	Poorly immunogenic
Heat Stability	Usually heat-labile	Heat-stable

Barriers to Pathogen Invasion

The human body employs multiple physical and chemical barriers to prevent pathogen colonization and infection.

• Normal Microbiota: Compete with pathogens for nutrients and attachment sites, providing a form of natural resistance (competitive exclusion).

• Physical Barriers: Skin, mucous membranes, and mechanical actions (e.g., swallowing, sneezing) remove microbes.

• Chemical Barriers: Secretions such as lysozyme, acidic pH, and antimicrobial peptides inhibit microbial growth.

• Disruption of Microbiota: Antibiotic use can disrupt normal microbiota, increasing susceptibility to opportunistic infections.

Epidemiological Terms: Scope of Disease

• Epidemic: Unusually high number of cases in a population.

• Pandemic: Widespread, often global epidemic.

• Endemic: Constantly present at low levels in a population; infected individuals serve as reservoirs.

Key Equations

• Lethal Dose 50 (LD50): $LD_{50} = \text{Number of cells (or virions) required to kill 50\% of the host population}$

• cAMP Formation (Cholera Toxin): $ATP \xrightarrow{\text{adenylate cyclase}} cAMP + PP_i$

Example Applications:

• Vaccine Development: Attenuated strains are used to produce effective vaccines (e.g., MMR vaccine).

• Clinical Diagnosis: The LAL assay is used to detect endotoxin contamination in injectable drugs and clinical fluids.

• Medical Therapy: Streptokinase is used to dissolve blood clots in heart attack and stroke patients; botulinum toxin is used therapeutically for chronic pain and muscle disorders.

Additional info: This summary integrates foundational concepts of microbial pathogenesis, including mechanisms of adherence, colonization, invasion, virulence, and host defense, as well as the roles of toxins and enzymes in disease. It also covers the genetic basis of virulence and the importance of host factors in susceptibility to infection.